IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

NCT06349408 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor

Interventions

DRUG: IBI3001

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.